MagBio Launches its Novel cfKapture 21 Kit
MagBio Genomics is proud to introduce the cfKapture 21 kit, a revolutionary solution for the isolation of circulating Cell-Free DNA (ccfDNA) from stabilized plasma samples. This cutting-edge system includes a proprietary reagent that effectively prevents post-separation degradation of plasma and ccfDNA fragments for up to 21 days at room temperature.
With the cfKapture 21 kit, laboratories can now transport and process samples within an extended timeframe without the need for extensive cold chain requirements. This not only enhances efficiency and reduces costs but also expands outreach capabilities for both local and international samples.
What sets the cfKapture 21 kit apart is its unparalleled flexibility in processing plasma samples in a high-throughput setting. It is compatible with any whole blood collection tube and can be seamlessly combined with the MagBio Blood STASIS 21-ccfDNA tube to ensure maximum quality ccfDNA recovery, suitable for a wide range of liquid biopsy applications.
The MagBio Blood STASIS 21-ccfDNA system offers a direct draw whole blood collection solution with a proprietary blood stabilization reagent. It is designed to meet the demands of cancer genomic research and Non-invasive Prenatal Testing (NIPT), making it compatible with almost all liquid biopsy applications.
By using the MagBio cfKapture 21 kit in conjunction with the Blood STASIS 21-ccfDNA tube, laboratories can achieve a cost-effective solution for blood sampling and ccfDNA isolation. The kit eliminates the need for frozen shipment with dry ice during the transport cycle, ensuring the integrity of ccfDNA within the plasma samples.
Addressing the critical challenge of stabilizing plasma samples during transport, the cfKapture 21 purification kit empowers researchers to obtain meaningful data from ccfDNA. Its unique reagent enables short-term transport and storage of separated plasma at room temperature for up to 21 days, while maintaining the stability of ccfDNA.
With its exceptional features, the cfKapture 21 kit provides unmatched flexibility in plasma sample processing and delivers significant cost savings associated with sample handling in both manual and automated ccfDNA isolation settings. MagBio Genomics continues to innovate to meet the evolving needs of genomic research and diagnostics.
